Is it possible to offer evidence-based treatment for systemic vasculitis?: Editorial review

Reference

• Scott DGI, Watts RA. Classification and epidemiology of systemic vasculitis. Br J Rheumatol 1994;33:897–900.
   PubMedGoogle Scholar
• Walton EW. Giant-cell granuloma of the respiratory tract. Br Med J 1958;2:265–70.
   PubMed Web of Science ®Google Scholar
• Carrington CB, Liebow AA. Limited forms of angiitis and granulomatosis of the Wegener's type. Am J Med 1966;41:497–527.
   PubMed Web of Science ®Google Scholar
• Leib ES, Restivo C, Paulus HC. Immunosuppressive and corticosteroid therapy of periarteritis nodosa. Am J Med 1979;67:941–7.
   Google Scholar
• Hollander D, Manning RT. The use of alkylating agents in the treatment of Wegener's granulomatosis. Ann Intern Med 1967;67:393–8.
   PubMed Web of Science ®Google Scholar
• Pickering G, Bywaters EGL, Danielli JF, Gell PG, Kellgren JH, Long DA, Neuberger A, et al. Treatment of polyarteritis nodosa. Results after three years: report to the Medical Research Council by the Collagen Disease and hypersensitiv-ity panel. Br Med J 1960;i:1399–1400.
   Google Scholar
• Hoffmann GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener's granulo-matosis: an analysis of 158 patients. Ann Int Med 1992;116:488–98.
   PubMedGoogle Scholar
• Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, et al. Relapses in patients with a systemic vasculitis. QJM 1993;86:779–89.
   PubMedGoogle Scholar
• Exley AR, Bacon PA, Luqmani RA, Kitas GD, Carruthers DM, Moots R. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index. Br J Rheum 1998;37:57–63.
   PubMedGoogle Scholar
• Mason PD, Pusey CD. Glomerulonephritis: Diagnosis and treatment. BMJ 1994;309:1557–63.
   PubMedGoogle Scholar
• Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. QJM 1948;17:175–202.
   Google Scholar
• Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187–92.
   PubMed Web of Science ®Google Scholar
• van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1(8426):425–9.
   PubMed Web of Science ®Google Scholar
• Colby TV, Tazelaar HD, Specks U, De Remee RA. Nasal biopsy in Wegener's granulomatosis. Human Pathol 1991;22:101–4.
   Google Scholar
• Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s - Is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritits? J R Coll of Physicians Lond 1990;24: 284–8.
   Google Scholar
• Scott DGI, Bacon PA, Elliott PJ, et al. Systemic vasculitis in a district general hospital 1972-1980: a clinical and laboratory features, classification and prognosis of 80 cases. Medicine (Baltimore) 1982;60:288–297.
   Google Scholar
• Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671–8.
   PubMed Web of Science ®Google Scholar
• Luqmani RA, Exley AR, Kitas GD, Bacon PA. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 1997;11:423–46.
   PubMed Web of Science ®Google Scholar
• Brijker F, Magee CC, Cohen Tervaert JW, O'Neill S, Walshe JJ. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol 1999;52:344–51.
   Google Scholar
• Exley AR, Bacon PA, Luqmani RA, Kitas GD, Banbury P, Gordon C. Development and initial validation of the vasculitis damage index for the standardised clinical assess-ment of damage in the systemic vasculitides. Arthritis Rheum 1997;40:371–80.
   PubMed Web of Science ®Google Scholar
• Wiik AS. Anti-neutrophil cytoplasmic antibodies in primary small vessel vasculitides. Scand J Rheumatol 1996;25:65–9.
   PubMed Web of Science ®Google Scholar
• Cohen Tervaert JW, Huitema MG, Hene RJ, et al. Prevention of relapses of Wegener's granulomatosis by treatment based on anti-meutrophil cytoplasmic antibody titre. Lancet 1990;336:709–11.
   PubMed Web of Science ®Google Scholar
• Halma C, Daha MR, Schrama E, Hermans J, Van Es LA, Van Der Woude FJ. Value of anti-neutrophil cytoplasmic autoantibodies and other laboratory parameters in follow-up of vasculitis. Scand J Rheumatol 1990;19:392–7.
   Google Scholar
• Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrohil cytoplasmic antibody titre in patients with Wegener's granulomatosis. Arthritis Rheum 1993;36:365–71.
   PubMed Web of Science ®Google Scholar
• Cockwell P, Tse WY, Savage COS. Activation of endothelial cells in thrombosis and vasculitis. Scand J Rheumatol 1997;26:145–50.
   Google Scholar
• Sais G, Vidaller A, Jucgla A, Gallardo F, Peyri JJN. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis: Results of a prospective, randomized controlled trial. Arch Dermatol 1995;131:1399–1402.
   Google Scholar
• Thuong-Nguyen V, Kadunce D, Hendrix J, et al. Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism in dapsone treatment. J Invest Dermatol 1993;100:349–55.
   Google Scholar
• Chen K-R. Cutaneous polyarteritis nodosa: a clinical and histopathological study of 20 cases. J Dermatol 1989;16: 429–42.
   PubMedGoogle Scholar
• Andersson R, Malmvall BE, Bengtsson B-A. Long-term corticosteroid treatment in giant cell arteritis. Acta Med Scand 1986;220:465–9.
   Google Scholar
• De Silva M, Hazleman BL. Azathioprine in giant cell arteritis/ polymyalgia rheumatica: A double-blind study. Ann Rheum Dis 1986;45:136–8.
   PubMed Web of Science ®Google Scholar
• Hoffman G. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol 1996;54 Suppl:S99–S102.
   Google Scholar
• Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS. An analysis of forty two Wegener's granulomatosis patients treated with methotrexate and pred-nisone. Arthritis Rheum 1995;38:608–13.
   Google Scholar
• Langford CA, Talar-Williams C, Barron KS, Sneller MC. A staged approach to the treatment of Wegener's granuloma-tosis. Arthritis Rheum 1999;42:2666–73.
   PubMed Web of Science ®Google Scholar
• Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P. Controlled trial of pulse versus continuous prednisolone and cyclophophamide in the treatment of systemic vasculitis. QJM 1997;90:401–9.
   PubMed Web of Science ®Google Scholar
• Luqmani R, Jayne D, European Vasculitis Study Group. A multi-centre randomised controlled trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (CYCAZAREM). Arthritis Rheum 1999;42 Suppl:5225.
   Google Scholar
• Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y, Silman A. A controlled trial of azathioprine in Behcet's syndrome. New Engl J Med 1990;322:281–5.
   PubMed Web of Science ®Google Scholar
• Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K. Epidemiological features and visual prognosis of Behcet's disease. Jpn J Ophthalmol 1999;43:312–7.
   Google Scholar
• Georgiou S, Monastirli A, Pasmatzi E, Gartaganis S, Goerz G, Tsambaos D. Efficacy and safety of systemic recombinant interferon-alpha in Behcet's disease. J Intern Med 1998; 243:367–72.
   PubMed Web of Science ®Google Scholar
• Guillevin L, Cordier J-F, Lhote F, Cohen P, Jarousse B, Royer I, et al. A prospective multi center randomised trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalised Wegener's granulomatosis. Arthritis Rheum 1997;40:2187–98.
   Google Scholar
• Haubitz M, Schellong S, Gobel U, Schurek HJ, Schaumann D, Koch KM. Intravenous pulse administration of cyclo-phosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study. Arthritis Rheum 1998;41:1835–44.
   PubMedGoogle Scholar
• Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990;89:403–10.
   Google Scholar
• Guillevin L, Le THD, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg Strauss angiitis a study in 165 patients. Br J Rheumatol 1988;27: 258–66.
   Google Scholar
• Gayraud M, Guillevin L, Cohen P, Lhote F, Cacoub P, Deblois P, et al. Treatment of good prognosis polyarteritis nodosa and Churg Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide. Br J Rheumatol 1997;36:1290–7.
   PubMedGoogle Scholar
• Pusey C, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757–63.
   Google Scholar
• Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Genereau T. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclo-phosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis: A prospective, randomised trial in sixty-two patients. Arthritis Rheum 1995;38: 1638–45.
   Google Scholar
• Rasmussen N, Jayne DRW, Abramowicz A, Andrassy K, Bacon PA, Cohen Tervaert JW, et al. European therapeutic trials in ANCA-associated vasculitis: disease scoring, con-sensus regimens and proposed clinical trials. Clin Exp Immunol 1995;101 Suppl 1:29–34.
   Google Scholar
• Guillevin L, Lhote F, Leon A, Fauvelle F, Vivitski L, Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol 1993;20:289–98.
   Google Scholar
• Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R. Interferon-alpha in mixed cryoglobulinemia patients: A randomized, crossover-controlled trial. Blood 1993;81:1132–6.
   PubMed Web of Science ®Google Scholar
• Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. New Engl J Med 1994;330: 751–6.
   Google Scholar
• Mazzaro C, Lacchin T, Moretti M, Tulissi P, Manazzone O, Colle E, et al. Effects of two different alpha-interferon regimens on clinical and virological findings in cryoglobulin-aemia associated with hepatitis C virus. Clin Exp Rheumatol 1995;13 Suppl:5181–S185.
   Google Scholar
• Donada C, Crucitti A, Donadon V, Chemello L, Alberti A. Interferon alpha and ribavirin combination therapy in patients with chronic hepatitis c and mixed cryoglobulinemia. Blood 1998;92:2983–4.
   Google Scholar
• Misiani R, Bellavita P. Mixed cryoglobulinaemia. A guide to drug treatment. Clin Immunother 1996;5:115–21.
   Google Scholar
• D'Amico G, Madias NE, Fornasieri A, Ferri C, Sansonno D, Bombardieri S. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54:650–71.
   PubMed Web of Science ®Google Scholar
• Newburger JW, Takahashi M, Burns JC, Beiser A, Chung K, Colan S, Duffy E, Fulton D, Glode M, et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. New Engl J Med 1986;315:341–7.
   PubMed Web of Science ®Google Scholar
• Hagen EC, de Keizer RJW, Andrassy K, van Boven WPL, Bruijn JA, van Es LA, et al. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globu-lin. Clin Nephrol 1994;43:351–9.
   Google Scholar
• Lockwood CM, Thiru S, Isaacs JD, Hale G, Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 1993;341:1620–2.
   Google Scholar
• Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, Van der Woude FJ. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic poly-angiitis: A pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999;10: 1965–71.
   Google Scholar
• Metzler C, Low-Friedrich I, Reinhold-Keller E, Schmitt WH, Gross WL. Leflunomide, a new promising agent in main-tenance and remission in Wegener's granulomatosis. Clin Exp Immunol 1998;112:56.
   Google Scholar
• Stone J, Hellmann DB, Uhlfelder MI, Bedocs NM, Crook SL, Holbrook J. Etanercept in Wegener's granulomatosis (WG). Results of an open-label trial. Arthritis Rheum 1999;42 Suppl:5315.
   Google Scholar